Cambridge Investment Research Advisors, Inc. Exscientia PLC Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.4 Billion
- Q3 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Exscientia PLC stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 19,857 shares of EXAI stock, worth $96,107. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,857Holding current value
$96,107% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding EXAI
# of Institutions
101Shares Held
33.5MCall Options Held
500Put Options Held
189K-
Sb Global Advisers LTD London, X05.68MShares$27.5 Million3.51% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M05.68MShares$27.5 Million0.13% of portfolio
-
Laurion Capital Management LP New York, NY4.47MShares$21.6 Million0.3% of portfolio
-
Baillie Gifford & CO3.85MShares$18.6 Million0.01% of portfolio
-
Bill & Melinda Gates Foundation Seattle, WA1.59MShares$7.7 Million17.85% of portfolio
About Exscientia plc
- Ticker EXAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 122,461,000
- Market Cap $593M
- Description
- Exscientia plc, an artificial intelligence-driven pharmatech company, engages in discovering, designing, and developing drugs. The company offers end-to-end solution of artificial intelligence (AI) and technologies for target identification, drug candidate design, translational models, and patient selection. In addition, the company focuses on s...